PET Imaging in Preclinical Anti-Aβ Drug Development

Positron emission tomography (PET), a medical imaging technique allowing for studies of the living human brain, has gained an important role in clinical trials of novel drugs against Alzheimer’s disease (AD). For example, PET data contributed to the conditional approval in 2021 of aducanumab, an ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Syvänen, Stina, Meier, Silvio R., Roshanbin, Sahar, Xiong, Mengfei, Faresjö, Rebecca, Gustavsson, Tobias, Bonvicini, Gillian, Schlein, Eva, Aguilar, Ximena, Julku, Ulrika, Eriksson, Jonas, Sehlin, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246809/
https://www.ncbi.nlm.nih.gov/pubmed/35501533
http://dx.doi.org/10.1007/s11095-022-03277-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246809/
https://www.ncbi.nlm.nih.gov/pubmed/35501533
http://dx.doi.org/10.1007/s11095-022-03277-z

Ejemplares similares